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Reiter’s syndrome belongs to the family of spondyloarthropathies that usually present with a triad of arthritis, 
urethritis, and uveitis. The diagnostic criteria include clinical, radiological, and genetic findings, and the response to 
treatment. Nervous system involvement in Reiter’s syndrome is extremely rare. We report here on a 36-year-old 
man who initially presented with progressive cervical myelopathy and was diagnosed as Reiter’s syndrome 2 years 
later. The myelopathy was stable after treatment with methotrexate and sulfasalazine. This case suggests that 
Reiter’s syndrome can present as progressive myelopathy and should be considered in the differential diagnosis of 
treatable myelopathies.
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Reiter’s syndrome is an aseptic arthritis that is 
triggered by an infectious agent located outside the 
joint. It has a strong association with human leukocyte 
antigen-B27 (HLA-B27). Enteric infection with sal-
monella or other microorganisms has been implicated 
as a trigger for this syndrome. Since Reiter’s original 
description of the tetrad of urethritis, conjunctivitis, 
arthritis, and other mucocutaneous lesions in 1916, 
cases of multiple-organ involvement in patients with 
classic Reiter’s syndrome have been documented.
1 
Central or peripheral nervous system involvement in 
Reiter’s syndrome has been well recognized, but this 
particular condition is very uncommon. This is the 
first Korean report of the long-term clinical course of 
a patient with progressive myelopathy and Reiter’s 
syndrome.
CASE REPORT
A previously healthy 36-year-old man presented 
with slowly progressive spastic paraparesis, impairment 
of vibration, and pain perception below the upper 
trunk associated with constipation, urinary difficulty, 
and sexual dysfunction. He had experienced lower 
abdominal pain and vomiting 7 months before the 
onset of these symptoms, and subsequently noticed a 
tingling sensation in the right leg and voiding 
difficulties.
The neurologic examination performed at the time 
of his first visit to our clinic was compatible with a 
spinal cord lesion: there was bilateral hypesthesia 
below the T10 level, hyperactive knee and ankle 




Figure 1. (A) T2-weighted sagittal and axial spine MRI 
demonstrated an area of high signal intensity in the 
spinal cord at the level of C7 and Th1, and mild swelling 
of the cord (arrow). The lesion exhibited a slightly low 
signal intensity on precontrast T1-weighted imaging and 
no enhancement after contrast administration (arrow in 
right image). (B) Follow-up T2-weighted sagittal spine 
MRI after the first steroid pulse therapy revealed a new 
linear lesion with a high signal intensity in the posterior 
portion of the spinal cord at the level of C7 to Th1 
(arrow).
enced voiding difficulties and a urinary tract infection. 
T2-weighted magnetic resonance imaging (MRI) of 
the spine showed a lesion with a high signal intensity 
and mild swelling that was not enhanced after the 
administration of contrast material in the cervical 
spinal cord (Fig. 1). The cerebrospinal fluid (CSF) 
was clear and colorless with 5 white blood cells/μL, 
and the cells were mostly lymphocytes. Electrophoresis 
of CSF was negative for the oligoclonal band, and 
the IgG index was within the normal range. The 
laboratory findings for rheumatoid factor, antinuclear 
antibody, antineutrophil cytoplasmic antibodies, cryo-
globulinemia, hepatitis B and C, and human immuno-
deficiency virus were negative. The erythrocyte sedi-
mentation rate and C-reactive protein and complement 
levels (C3, C4, and CH50) were normal. The results 
for the visual evoked potential and brain MRI were 
negative. The patient was treated with steroid pulse 
therapy under a diagnosis of transverse myelitis. He 
complained of intermittent chest discomfort when 
subsequently visiting our clinic, but electrocardiography, 
cardiac enzymes, and echocardiography findings were 
normal.
The first steroid pulse therapy provided temporary 
relief from bilateral hypesthesia and paresthesia, but 
he still experienced spastic paraparesis with painful 
tonic spasm and bladder dysfunction including recurrent 
urinary tract infection and nonspecific anterior chest Kim SK, et al. Reiter’s Syndrome with Progressive Myelopathy
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Figure 2. 
99mTc methylene diphosphonate whole-body bone scan showed active lesions in the left costomanubrial junction and first 
rib (arrow) (A). Pelvis anteroposterior radiograph demonstrated symmetrical joint space obliteration in the upper two-thirds of both 
sacroiliac joints (arrow) (B).
Figure 3. Swollen costochondral joint (arrow) and multiple 
pustular skin eruptionson the neck and trunk. The rash 
appeared as crops of clear, deep-seated, tapioca-like vesicles, 
and was very itchy. Results of a skin puncture biopsy were 
consistent with dyshidrotic dermatitis.
tenderness, especially in the costochondral joint area. 
However, the spastic paraparesis slowly deteriorated 
and paresthesia relapsed in the lower extremities. 
Another two cycles of steroid pulse therapy were 
administered during the 2 years following the first 
treatment due to progression of sensory and motor 
symptoms. Follow-up spine MRI after the second 
steroid pulse therapy revealed recurrence of intra-
medullary myelopathy (Fig. 1-B). Two years after the 
onset of myelopathy, he developed painful swelling 
of his costochondral joints and both knees. A 
99mTc 
methylene diphosphonate bone scan showed markedly 
increased uptake in the left costomanubrial junction 
and the first rib (Fig. 2-A). Pelvis radiographs showed 
ankylosis of bilateral hip joints and poorly delineated 
bilateral sacroiliac joints (Fig. 2-B). He subsequently 
displayed multiple pustular skin eruptions on the 
palms of the hands, soles of the feet, elbows, trunk 
(Fig. 3), and glans penis. He was positive for HLA- 
B27 antigen. Administration of methotrexate and 
sulfasalazine markedly reduced the patient’s arthralgia 
and neurologic symptoms, which were stabilized by 
maintenance therapy with methotrexate and prednisolone.
DISCUSSION
The spondyloarthropathies comprise a diverse group 
of inflammatory arthritis conditions that share certain 
genetic predisposing factors and clinical features. 
The pathogenesis of spondyloarthropathies is still not 
well defined. Recent studies have provided insight 
into distinct pathogenetic mechanisms underlying 
ankylosing spondylitis and reactive arthritis that arise Journal of Clinical Neurology: Vol. 3, No. 4, 2007
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from a complex interplay between genetic factors 
(including HLA-B27) and environmental factors.
2 
The pathogenesis of Reiter’s syndrome may involve 
molecular mimicry between bacterial fragments in 
synovial fluid and the HLA-B27 molecule. Most 
(70-80%) patients with Reiter’s syndrome are positive 
for HLA-B27, as compared with only 6% of the 
general population. The arthritis may be perpetuated 
by the induction of cytotoxic T lymphocytes by 
microbial fragments in the joints, but these cytotoxic 
T lymphocytes have specificity for HLA-B27-positive 
cells. The presence of HLA-B27 may allow stronger 
or persistent microbial invasion.
3
Reactive arthritis usually has a self-limited course 
of 3 to 12 months, but up to 50% of patients ex-
perience recurrent bouts of arthritis, and 15% to 30% 
of them develop chronic symptoms of the disease.
4 
Extra-articular manifestations such as ocular infla-
mmation, enteritis, mucocutaneous lesions, urethritis, 
and (rarely) carditis provide essential support for a 
diagnosis of reactive arthritis. However, neurological 
complications are rare.
5 There have been only a few 
case reports of polyneuropathy, cranial nerve palsy, 
or myelopathy in Reiter’s syndrome.
6,7
Whilst there were gastrointestinal symptoms in 
this case, stool examinations provided no laboratory 
evidence of preceding infection. There also was no 
preceding urethral discharge or notable infections. 
The patient visited our clinic at 7 months after the 
onset of the first symptoms. The high dose of steroids 
administered might have inhibited a systemic inflamma-
tory reaction. According to a previous report, approxi-
mately only 60% of such cases have evidence of 
previous infection detected either by serology or by 
cultures from urogenital or stool samples.
8 Nonsteroid 
anti-inflammatory drugs (NSAIDs) and sulfasalazine 
are effective treatments for reactive arthritis, and 
methotrexate can also be beneficial.
9 Our patient did 
not respond to NSAIDs, but methotrexate and sul-
fasalazine relieved his neurological symptoms and 
arthralgia, making them stable during a 5-year follow-up.
The association between reactive arthritis and 
cervical myelopathy was not clear in this patient, but 
there were some features suggesting Reiter’s syndrome 
as a cause of the myelitis. First, the gastrointestinal 
symptoms that appeared before the development of 
cervical myelopathy might have reflected a preceding 
infection that initiated an autoimmune reaction, which 
led to myelitis and systemic inflammation. Initial 
urinary tract infection and costochondral tenderness 
at the time of the first attack of myelitis might be 
indicative of Reiter’s syndrome. Second, despite the 
application of steroid pulse therapy, recurrences of 
progressive myelopathy associated with systemic 
symptoms of the skin and joints, and the positivity 
for HLA-B27 suggest other causes of myelitis. Third, 
both neurological symptoms and the arthritis that was 
resistant to the steroid pulse therapy did not recur after 
sulfasalazine and methotrexate treatment. 
In conclusion, Reiter’s syndrome should be considered 
in the differential diagnosis of cases of progressive 
myelopathy with multiple arthritis, urethritis, and skin 
lesions.
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